chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: I have two booster; I got sick; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (I have two booster; I got sick) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056M21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Asthma. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, LAMOTRIGINE for an unknown indication.   On 16-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I have two booster; I got sick). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) on 30-May-2022 for COVID-19 treatment, at a dose of 3 tablets for 5 days. At the time of the report, ILLNESS (I have two booster; I got sick) outcome was unknown.    Patient took two booster Moderna Covid-19 vaccine, and got sick, they put patient on Paxlovid. Patient seems to work fine about five days after finishing Paxlovid. Patient started getting like cold symptoms and that was about two days ago cold symptoms, yellow sputum which is now turning more clear and patient took a covid test and it was positive so, patient think he had rebound covid. Symptoms reported by patient as very very tired. Patient further stated that patient was not experiencing side effect because of the vaccination it was due to Paxlovid. Patient was taking cold medications, herbal cold medications because he thought he had cold when one's he finished Paxlovid and symptoms came back like cold but today he tested positive for covid." When probed if adverse events are worsening, improved and persisting. Patient stated, "No well he don't if it is a covid rebound is a side effect of Paxlovid.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Upon internal review on 05-July-2022, significant correction was performed. Moderna vaccine was removed from historical vaccine and added in product tab. Removed the classification of Tracking only.
Sex: U
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: knocked me sideways; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (knocked me sideways) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (knocked me sideways). At the time of the report, IMMUNISATION REACTION (knocked me sideways) outcome was unknown. Concomitant drugs were not reported. The patient just had fourth jab as it was six months since patient had booster. Patient had Pfizer again after Moderna booster. Treatment details were not given. Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Rash
Clinical narrative: Can't breath; Rash; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Can't breath) and RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Can't breath) and RASH (Rash). At the time of the report, DYSPNOEA (Can't breath) and RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. No concomitant medications were provided. It was reported that reporter saw a study that a women gotten a moderna reaction that could not breath and rash. The study said they could not figured out why the women had a reaction. No treatment information was reported. Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: Had an allergic reaction with hives all over her body and in mouth/ she has a lot of allergies; Had an allergic reaction with hives all over her body and in mouth; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Had an allergic reaction with hives all over her body and in mouth/ she has a lot of allergies) and URTICARIA (Had an allergic reaction with hives all over her body and in mouth) in an 83-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Multiple allergies.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Had an allergic reaction with hives all over her body and in mouth/ she has a lot of allergies) and URTICARIA (Had an allergic reaction with hives all over her body and in mouth). At the time of the report, HYPERSENSITIVITY (Had an allergic reaction with hives all over her body and in mouth/ she has a lot of allergies) and URTICARIA (Had an allergic reaction with hives all over her body and in mouth) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication were reported.  The patient asked which version of the vaccine doesn't have the TRIS in it and how does the person administering the vaccine know when to give the formulation with the TRIS or not. Patient states she received the Moderna vaccine and had an allergic reaction with hives all over her body and in her mouth. Also states she thinks its the TRIS that made her react and she hopes it is not the MRNA.  Patient reports to the manufacture of Corminaty for medical information potential AE.  No treatment information were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-039158 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-039158:Other People case
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: Allergic Reaction; This spontaneous case was reported by a patient and describes the occurrence of ALLERGY TO VACCINE (Allergic Reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic Reaction). At the time of the report, ALLERGY TO VACCINE (Allergic Reaction) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     The patient had no allergies (medications, food and other products).  Concurrent medical conditions included Asthma (20 years ago. There was no change in status such as improvement or worsening.) and Diabetes (20 years ago. There was some improvement.). Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma, METFORMIN and EMPAGLIFLOZIN (JARDIANCE) for Diabetes.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2021, the patient experienced PAIN IN EXTREMITY (sore arm). In January 2021, PAIN IN EXTREMITY (sore arm) had resolved.            It was reported that after the second dose, the patient had experienced a sore arm for 1 or 2 days. The patient had not experienced a similar event in the past. The AE did not cause patient to seek medical care (office visit, Urgent care, ER, hospitalized). No treatment was given for the event.   This case was linked to MOD-2022-599990 (Patient Link).
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Illness, Loss of personal independence in daily activities
Clinical narrative: did not come in to work; was super sick; headaches; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (did not come in to work), ILLNESS (was super sick) and HEADACHE (headaches) in a 33-year-old male patient who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (did not come in to work), ILLNESS (was super sick) and HEADACHE (headaches). At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (did not come in to work), ILLNESS (was super sick) and HEADACHE (headaches) outcome was unknown.     No concomitant medication was reported.  No treatment medication was reported.
Sex: U
Vaccine: COVID19
Symptoms: Pityriasis rosea
Clinical narrative: Pityriasis rosea; This is a spontaneous report received from contactable reporter(s) (Physician) from a sales representative.  A 12-year-old patient received BNT162b2 (BNT162B2), on 12May2021 as dose 1, single (Lot number: ER8737) intramuscular for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PITYRIASIS ROSEA (non-serious) with onset 15May2021, outcome "recovered" (May2021). The event "pityriasis rosea" required physician office visit. Therapeutic measures were not taken as a result of pityriasis rosea.  Additional information: Event took place after use of product. Pfizer product had a causal effect to the adverse event was reported as Yes (Possibly). Prior vaccination and relevant tests was reported as None. Family medical history relevant to AE was reported as Not applicable. AE required visit to Dermatology.  Follow-up attempts are completed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previous information: Re-assessed the case as valid.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium, Additional Details: Patient has sore arm. Painful shot
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for covid
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Arterial stenosis, Asthenia, COVID-19
Clinical narrative: Pfizer Dose 1 10/25/22 (FF2593) COVID Positive 1/18/22  1/15/22: 63-year-old female patient who appears much older than his stated age with a history of CAD, chronic pain, fibromyalgia, GERD, COPD with 2 L of oxygen dependency, rheumatoid arthritis, CVA, anxiety, depression, Nissen fundoplication in 2014 and ostomy bag on the right side of her abdomen was recently discharged from the hospital on 1/12/2022.  Patient was recommended to be transferred to a skilled nursing facility but she adamantly refused and went home with VNA.  The patient had a visit from the nursing staff and noted the patient was extremely weak and fatigued and her oral intake was very poor and hence paramedics were called in and the patient is currently admitted to the hospital for weakness and subsequent placement.   Patient has no new medical complaints.  Case manager in the emergency room he is unable to place the patient at the skilled  nursing facility or the weekend and hence she has been admitted for observation.  Patient complains of chronic pain and also has leakage around the ostomy bag which the patient states that she has an appointment set up as an outpatient with surgery but has not even been able to keep it up.  Patient was also recently admitted to the Hospital.   The patient was admitted to the Hospital and discharged on 01/12 for left brachial artery stenosis with left upper extremity ischemia on anticoagulation, GI bleed with the normal EGD, acute renal failure.  The patient was advised to take aspirin for her peripheral arterial disease and no other medication recommended per vascular surgery due to history of GI bleed.  Patient has no new complaints of GI bleed currently.  1/20/22: 63-year-old female with history of COPD and chronic hypoxic respiratory failure on 2 L by nasal cannula, history of severe peripheral arterial disease, history of antral ulcer and GI bleed, history of ileostomy, presented to the emergency department due to generalized weakness.  Admitted for possible placement.  Patient was doing well, lab work showed severe renal failure secondary to volume depletion hypertension.  Nephrology consulted, patient was started on bicarb drip, was started on hydrocortisone does in addition to home dose liver enough and midodrine.  Blood pressure relatively improved.  Kidney function improved.  Patient had 1 episode of hematemesis and GI bleeding, GI consulted and she underwent upper endoscopy that showed Mallory-Weiss tear s/p clipping. Patient continues to not feel well overall with no specific symptoms, she tested positive for COVID-19 infection but she did not have any pneumonia.  She was stable for discharge.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Endoscopy upper gastrointestinal tract abnormal, Fatigue, Gastrointestinal haemorrhage, Haematemesis, Haemostasis
Clinical narrative: Pfizer Dose 1 10/25/22 (FF2593) COVID Positive 1/18/22  1/15/22: 63-year-old female patient who appears much older than his stated age with a history of CAD, chronic pain, fibromyalgia, GERD, COPD with 2 L of oxygen dependency, rheumatoid arthritis, CVA, anxiety, depression, Nissen fundoplication in 2014 and ostomy bag on the right side of her abdomen was recently discharged from the hospital on 1/12/2022.  Patient was recommended to be transferred to a skilled nursing facility but she adamantly refused and went home with VNA.  The patient had a visit from the nursing staff and noted the patient was extremely weak and fatigued and her oral intake was very poor and hence paramedics were called in and the patient is currently admitted to the hospital for weakness and subsequent placement.   Patient has no new medical complaints.  Case manager in the emergency room he is unable to place the patient at the skilled  nursing facility or the weekend and hence she has been admitted for observation.  Patient complains of chronic pain and also has leakage around the ostomy bag which the patient states that she has an appointment set up as an outpatient with surgery but has not even been able to keep it up.  Patient was also recently admitted to the Hospital.   The patient was admitted to the Hospital and discharged on 01/12 for left brachial artery stenosis with left upper extremity ischemia on anticoagulation, GI bleed with the normal EGD, acute renal failure.  The patient was advised to take aspirin for her peripheral arterial disease and no other medication recommended per vascular surgery due to history of GI bleed.  Patient has no new complaints of GI bleed currently.  1/20/22: 63-year-old female with history of COPD and chronic hypoxic respiratory failure on 2 L by nasal cannula, history of severe peripheral arterial disease, history of antral ulcer and GI bleed, history of ileostomy, presented to the emergency department due to generalized weakness.  Admitted for possible placement.  Patient was doing well, lab work showed severe renal failure secondary to volume depletion hypertension.  Nephrology consulted, patient was started on bicarb drip, was started on hydrocortisone does in addition to home dose liver enough and midodrine.  Blood pressure relatively improved.  Kidney function improved.  Patient had 1 episode of hematemesis and GI bleeding, GI consulted and she underwent upper endoscopy that showed Mallory-Weiss tear s/p clipping. Patient continues to not feel well overall with no specific symptoms, she tested positive for COVID-19 infection but she did not have any pneumonia.  She was stable for discharge.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypophagia, Hypovolaemia, Laboratory test abnormal, Malaise
Clinical narrative: Pfizer Dose 1 10/25/22 (FF2593) COVID Positive 1/18/22  1/15/22: 63-year-old female patient who appears much older than his stated age with a history of CAD, chronic pain, fibromyalgia, GERD, COPD with 2 L of oxygen dependency, rheumatoid arthritis, CVA, anxiety, depression, Nissen fundoplication in 2014 and ostomy bag on the right side of her abdomen was recently discharged from the hospital on 1/12/2022.  Patient was recommended to be transferred to a skilled nursing facility but she adamantly refused and went home with VNA.  The patient had a visit from the nursing staff and noted the patient was extremely weak and fatigued and her oral intake was very poor and hence paramedics were called in and the patient is currently admitted to the hospital for weakness and subsequent placement.   Patient has no new medical complaints.  Case manager in the emergency room he is unable to place the patient at the skilled  nursing facility or the weekend and hence she has been admitted for observation.  Patient complains of chronic pain and also has leakage around the ostomy bag which the patient states that she has an appointment set up as an outpatient with surgery but has not even been able to keep it up.  Patient was also recently admitted to the Hospital.   The patient was admitted to the Hospital and discharged on 01/12 for left brachial artery stenosis with left upper extremity ischemia on anticoagulation, GI bleed with the normal EGD, acute renal failure.  The patient was advised to take aspirin for her peripheral arterial disease and no other medication recommended per vascular surgery due to history of GI bleed.  Patient has no new complaints of GI bleed currently.  1/20/22: 63-year-old female with history of COPD and chronic hypoxic respiratory failure on 2 L by nasal cannula, history of severe peripheral arterial disease, history of antral ulcer and GI bleed, history of ileostomy, presented to the emergency department due to generalized weakness.  Admitted for possible placement.  Patient was doing well, lab work showed severe renal failure secondary to volume depletion hypertension.  Nephrology consulted, patient was started on bicarb drip, was started on hydrocortisone does in addition to home dose liver enough and midodrine.  Blood pressure relatively improved.  Kidney function improved.  Patient had 1 episode of hematemesis and GI bleeding, GI consulted and she underwent upper endoscopy that showed Mallory-Weiss tear s/p clipping. Patient continues to not feel well overall with no specific symptoms, she tested positive for COVID-19 infection but she did not have any pneumonia.  She was stable for discharge.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Mallory-Weiss syndrome, Oesophagogastroduodenoscopy normal, Pain, Peripheral ischaemia, SARS-CoV-2 test positive
Clinical narrative: Pfizer Dose 1 10/25/22 (FF2593) COVID Positive 1/18/22  1/15/22: 63-year-old female patient who appears much older than his stated age with a history of CAD, chronic pain, fibromyalgia, GERD, COPD with 2 L of oxygen dependency, rheumatoid arthritis, CVA, anxiety, depression, Nissen fundoplication in 2014 and ostomy bag on the right side of her abdomen was recently discharged from the hospital on 1/12/2022.  Patient was recommended to be transferred to a skilled nursing facility but she adamantly refused and went home with VNA.  The patient had a visit from the nursing staff and noted the patient was extremely weak and fatigued and her oral intake was very poor and hence paramedics were called in and the patient is currently admitted to the hospital for weakness and subsequent placement.   Patient has no new medical complaints.  Case manager in the emergency room he is unable to place the patient at the skilled  nursing facility or the weekend and hence she has been admitted for observation.  Patient complains of chronic pain and also has leakage around the ostomy bag which the patient states that she has an appointment set up as an outpatient with surgery but has not even been able to keep it up.  Patient was also recently admitted to the Hospital.   The patient was admitted to the Hospital and discharged on 01/12 for left brachial artery stenosis with left upper extremity ischemia on anticoagulation, GI bleed with the normal EGD, acute renal failure.  The patient was advised to take aspirin for her peripheral arterial disease and no other medication recommended per vascular surgery due to history of GI bleed.  Patient has no new complaints of GI bleed currently.  1/20/22: 63-year-old female with history of COPD and chronic hypoxic respiratory failure on 2 L by nasal cannula, history of severe peripheral arterial disease, history of antral ulcer and GI bleed, history of ileostomy, presented to the emergency department due to generalized weakness.  Admitted for possible placement.  Patient was doing well, lab work showed severe renal failure secondary to volume depletion hypertension.  Nephrology consulted, patient was started on bicarb drip, was started on hydrocortisone does in addition to home dose liver enough and midodrine.  Blood pressure relatively improved.  Kidney function improved.  Patient had 1 episode of hematemesis and GI bleeding, GI consulted and she underwent upper endoscopy that showed Mallory-Weiss tear s/p clipping. Patient continues to not feel well overall with no specific symptoms, she tested positive for COVID-19 infection but she did not have any pneumonia.  She was stable for discharge.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Stoma site extravasation
Clinical narrative: Pfizer Dose 1 10/25/22 (FF2593) COVID Positive 1/18/22  1/15/22: 63-year-old female patient who appears much older than his stated age with a history of CAD, chronic pain, fibromyalgia, GERD, COPD with 2 L of oxygen dependency, rheumatoid arthritis, CVA, anxiety, depression, Nissen fundoplication in 2014 and ostomy bag on the right side of her abdomen was recently discharged from the hospital on 1/12/2022.  Patient was recommended to be transferred to a skilled nursing facility but she adamantly refused and went home with VNA.  The patient had a visit from the nursing staff and noted the patient was extremely weak and fatigued and her oral intake was very poor and hence paramedics were called in and the patient is currently admitted to the hospital for weakness and subsequent placement.   Patient has no new medical complaints.  Case manager in the emergency room he is unable to place the patient at the skilled  nursing facility or the weekend and hence she has been admitted for observation.  Patient complains of chronic pain and also has leakage around the ostomy bag which the patient states that she has an appointment set up as an outpatient with surgery but has not even been able to keep it up.  Patient was also recently admitted to the Hospital.   The patient was admitted to the Hospital and discharged on 01/12 for left brachial artery stenosis with left upper extremity ischemia on anticoagulation, GI bleed with the normal EGD, acute renal failure.  The patient was advised to take aspirin for her peripheral arterial disease and no other medication recommended per vascular surgery due to history of GI bleed.  Patient has no new complaints of GI bleed currently.  1/20/22: 63-year-old female with history of COPD and chronic hypoxic respiratory failure on 2 L by nasal cannula, history of severe peripheral arterial disease, history of antral ulcer and GI bleed, history of ileostomy, presented to the emergency department due to generalized weakness.  Admitted for possible placement.  Patient was doing well, lab work showed severe renal failure secondary to volume depletion hypertension.  Nephrology consulted, patient was started on bicarb drip, was started on hydrocortisone does in addition to home dose liver enough and midodrine.  Blood pressure relatively improved.  Kidney function improved.  Patient had 1 episode of hematemesis and GI bleeding, GI consulted and she underwent upper endoscopy that showed Mallory-Weiss tear s/p clipping. Patient continues to not feel well overall with no specific symptoms, she tested positive for COVID-19 infection but she did not have any pneumonia.  She was stable for discharge.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Influenza like illness, Muscular weakness, Nasal congestion
Clinical narrative: Flu like symptoms. Fever, chills, nausea, muscle weakness, nasal congestion, tiredness.
Age: 53.0
Sex: M
Vaccine: VARZOS
Symptoms: Nausea, Pyrexia
Clinical narrative: Flu like symptoms. Fever, chills, nausea, muscle weakness, nasal congestion, tiredness.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Death, Full blood count abnormal, Haemoglobin decreased, Leukocytosis
Clinical narrative: 6/30/22 @ 1243 patient had stroke 7/6/22 @ 0938 patient expired
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative
Clinical narrative: 6/30/22 @ 1243 patient had stroke 7/6/22 @ 0938 patient expired
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Moderna 1/29/21, 2/22/21, 10/27/21. Positive on 7/6/22
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Back pain, Blood lactic acid increased, COVID-19
Clinical narrative: Pfizer Dose 1 3/20/21 (ER2613) Pfizer Dose 2 4/17/21 (EW0164) Pfizer Dose 3 9/21/21 (FF2588) COVID Positive 1/7/2022  1/7/22: The patient presents with worsening shortness of breath.  Onset: gradual .  Location: generalized. Context: The patient is a 60 year old male presents to the ED with worsening shortness of breath. He has associated fever, chills and body aches. The patient denies chest pain. He does not endorse any other pains and symptoms such as abdominal pain, nausea, and vomiting. The patient has a Hx hypertension, hyperlipidemia, diabetes, stage III renal disease and hepatic cancer with liver transplant. His transplant was done at hospital in 2009. The patient tested positive for COVID 19 recently. He was evaluated. Patient was hospitalized, while he was admitted he did require supplemental O2. He was recently discharged earlier in the week without any oxygen requirements. Today, he is requiring 3L via nasal canula which is new requirement for him. .  Timing: gradual. Character: moderate.  Associated Symptoms: moderate and fever, chills and body aches.  1/21/22: Severe septic shock with multi organ failure on Levophed, phenylephrine, Ang II, vasopressin, Adrenaline ;Family decided on comfort measures and patient expired  Acute hypoxemic respiratory failure due to  COVID-19 pneumonia  Possible superimposed hospital associated pneumonia   Alcoholic cirrhosis status post liver transplant in 2009, markedly elevated LFTs  and lactic acid, possibly shock liver  Chronic immunosuppression for liver transplant  Acute kidney injury on CKD stage IIIA   Diabetes mellitus with hyperglycemia  Hypertension, now hypotensive on pressors   Hyperlipidemia   Obesity  Chronic low back pain  Insomnia  Leucocytosis  The patient expired from progressive multiorgan failure due to Acute covid-19 infection while immunosuppressed and in the background of extensive comorbiditeis
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chills, Condition aggravated, Death, Dyspnoea
Clinical narrative: Pfizer Dose 1 3/20/21 (ER2613) Pfizer Dose 2 4/17/21 (EW0164) Pfizer Dose 3 9/21/21 (FF2588) COVID Positive 1/7/2022  1/7/22: The patient presents with worsening shortness of breath.  Onset: gradual .  Location: generalized. Context: The patient is a 60 year old male presents to the ED with worsening shortness of breath. He has associated fever, chills and body aches. The patient denies chest pain. He does not endorse any other pains and symptoms such as abdominal pain, nausea, and vomiting. The patient has a Hx hypertension, hyperlipidemia, diabetes, stage III renal disease and hepatic cancer with liver transplant. His transplant was done at hospital in 2009. The patient tested positive for COVID 19 recently. He was evaluated. Patient was hospitalized, while he was admitted he did require supplemental O2. He was recently discharged earlier in the week without any oxygen requirements. Today, he is requiring 3L via nasal canula which is new requirement for him. .  Timing: gradual. Character: moderate.  Associated Symptoms: moderate and fever, chills and body aches.  1/21/22: Severe septic shock with multi organ failure on Levophed, phenylephrine, Ang II, vasopressin, Adrenaline ;Family decided on comfort measures and patient expired  Acute hypoxemic respiratory failure due to  COVID-19 pneumonia  Possible superimposed hospital associated pneumonia   Alcoholic cirrhosis status post liver transplant in 2009, markedly elevated LFTs  and lactic acid, possibly shock liver  Chronic immunosuppression for liver transplant  Acute kidney injury on CKD stage IIIA   Diabetes mellitus with hyperglycemia  Hypertension, now hypotensive on pressors   Hyperlipidemia   Obesity  Chronic low back pain  Insomnia  Leucocytosis  The patient expired from progressive multiorgan failure due to Acute covid-19 infection while immunosuppressed and in the background of extensive comorbiditeis
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia, Hyperlipidaemia, Hypotension, Immunosuppression, Inappropriate schedule of product administration
Clinical narrative: Pfizer Dose 1 3/20/21 (ER2613) Pfizer Dose 2 4/17/21 (EW0164) Pfizer Dose 3 9/21/21 (FF2588) COVID Positive 1/7/2022  1/7/22: The patient presents with worsening shortness of breath.  Onset: gradual .  Location: generalized. Context: The patient is a 60 year old male presents to the ED with worsening shortness of breath. He has associated fever, chills and body aches. The patient denies chest pain. He does not endorse any other pains and symptoms such as abdominal pain, nausea, and vomiting. The patient has a Hx hypertension, hyperlipidemia, diabetes, stage III renal disease and hepatic cancer with liver transplant. His transplant was done at hospital in 2009. The patient tested positive for COVID 19 recently. He was evaluated. Patient was hospitalized, while he was admitted he did require supplemental O2. He was recently discharged earlier in the week without any oxygen requirements. Today, he is requiring 3L via nasal canula which is new requirement for him. .  Timing: gradual. Character: moderate.  Associated Symptoms: moderate and fever, chills and body aches.  1/21/22: Severe septic shock with multi organ failure on Levophed, phenylephrine, Ang II, vasopressin, Adrenaline ;Family decided on comfort measures and patient expired  Acute hypoxemic respiratory failure due to  COVID-19 pneumonia  Possible superimposed hospital associated pneumonia   Alcoholic cirrhosis status post liver transplant in 2009, markedly elevated LFTs  and lactic acid, possibly shock liver  Chronic immunosuppression for liver transplant  Acute kidney injury on CKD stage IIIA   Diabetes mellitus with hyperglycemia  Hypertension, now hypotensive on pressors   Hyperlipidemia   Obesity  Chronic low back pain  Insomnia  Leucocytosis  The patient expired from progressive multiorgan failure due to Acute covid-19 infection while immunosuppressed and in the background of extensive comorbiditeis
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Leukocytosis, Liver function test increased, Multiple organ dysfunction syndrome, Obesity
Clinical narrative: Pfizer Dose 1 3/20/21 (ER2613) Pfizer Dose 2 4/17/21 (EW0164) Pfizer Dose 3 9/21/21 (FF2588) COVID Positive 1/7/2022  1/7/22: The patient presents with worsening shortness of breath.  Onset: gradual .  Location: generalized. Context: The patient is a 60 year old male presents to the ED with worsening shortness of breath. He has associated fever, chills and body aches. The patient denies chest pain. He does not endorse any other pains and symptoms such as abdominal pain, nausea, and vomiting. The patient has a Hx hypertension, hyperlipidemia, diabetes, stage III renal disease and hepatic cancer with liver transplant. His transplant was done at hospital in 2009. The patient tested positive for COVID 19 recently. He was evaluated. Patient was hospitalized, while he was admitted he did require supplemental O2. He was recently discharged earlier in the week without any oxygen requirements. Today, he is requiring 3L via nasal canula which is new requirement for him. .  Timing: gradual. Character: moderate.  Associated Symptoms: moderate and fever, chills and body aches.  1/21/22: Severe septic shock with multi organ failure on Levophed, phenylephrine, Ang II, vasopressin, Adrenaline ;Family decided on comfort measures and patient expired  Acute hypoxemic respiratory failure due to  COVID-19 pneumonia  Possible superimposed hospital associated pneumonia   Alcoholic cirrhosis status post liver transplant in 2009, markedly elevated LFTs  and lactic acid, possibly shock liver  Chronic immunosuppression for liver transplant  Acute kidney injury on CKD stage IIIA   Diabetes mellitus with hyperglycemia  Hypertension, now hypotensive on pressors   Hyperlipidemia   Obesity  Chronic low back pain  Insomnia  Leucocytosis  The patient expired from progressive multiorgan failure due to Acute covid-19 infection while immunosuppressed and in the background of extensive comorbiditeis
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Pfizer Dose 1 3/20/21 (ER2613) Pfizer Dose 2 4/17/21 (EW0164) Pfizer Dose 3 9/21/21 (FF2588) COVID Positive 1/7/2022  1/7/22: The patient presents with worsening shortness of breath.  Onset: gradual .  Location: generalized. Context: The patient is a 60 year old male presents to the ED with worsening shortness of breath. He has associated fever, chills and body aches. The patient denies chest pain. He does not endorse any other pains and symptoms such as abdominal pain, nausea, and vomiting. The patient has a Hx hypertension, hyperlipidemia, diabetes, stage III renal disease and hepatic cancer with liver transplant. His transplant was done at hospital in 2009. The patient tested positive for COVID 19 recently. He was evaluated. Patient was hospitalized, while he was admitted he did require supplemental O2. He was recently discharged earlier in the week without any oxygen requirements. Today, he is requiring 3L via nasal canula which is new requirement for him. .  Timing: gradual. Character: moderate.  Associated Symptoms: moderate and fever, chills and body aches.  1/21/22: Severe septic shock with multi organ failure on Levophed, phenylephrine, Ang II, vasopressin, Adrenaline ;Family decided on comfort measures and patient expired  Acute hypoxemic respiratory failure due to  COVID-19 pneumonia  Possible superimposed hospital associated pneumonia   Alcoholic cirrhosis status post liver transplant in 2009, markedly elevated LFTs  and lactic acid, possibly shock liver  Chronic immunosuppression for liver transplant  Acute kidney injury on CKD stage IIIA   Diabetes mellitus with hyperglycemia  Hypertension, now hypotensive on pressors   Hyperlipidemia   Obesity  Chronic low back pain  Insomnia  Leucocytosis  The patient expired from progressive multiorgan failure due to Acute covid-19 infection while immunosuppressed and in the background of extensive comorbiditeis
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: 8 days after the 1st dose, my daughter developed a red rash on the same arm of the injection site - about an inch below where the shot was given.  The rash was about 2-3 inches in size.  It did not bother her.  It lasted 2 days and resolved on its own.
Age: 32.0
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Underdose
Clinical narrative: Pediatric Hep A administered; Adult Hep A ordered.  Will have patient return to clinic to receive Adult Hep A  vaccine.  No adverse signs/symptoms. Vaccine administered by MA
Age: 32.0
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pediatric Hep A administered; Adult Hep A ordered.  Will have patient return to clinic to receive Adult Hep A  vaccine.  No adverse signs/symptoms. Vaccine administered by MA
Age: 32.0
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Underdose
Clinical narrative: Pediatric Hep A administered; Adult Hep A ordered. Will have patient return to clinic to receive Adult Hep A vaccine. No adverse signs/symptoms. Vaccine was prepared by medical assistant and administered by CMA
Age: 32.0
Sex: F
Vaccine: HEPA, HEPA
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pediatric Hep A administered; Adult Hep A ordered. Will have patient return to clinic to receive Adult Hep A vaccine. No adverse signs/symptoms. Vaccine was prepared by medical assistant and administered by CMA
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse events or treatment required.   Vaccine was expired at time of administration.  Case has had no issues or trouble since given vaccine.  Vaccine expired 4/13/2022
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain, Abdominal pain lower, COVID-19, Computerised tomogram abdomen abnormal
Clinical narrative: Pfizer Dose 1 4/18/21 (lot NA) Pfizer Dose 2 5/13/21 (lot NA) COVID Positive 1/4/22  1/4/22: 50 year old female with PMHx of laparoscopic cholecystectomy 8/2018 followed by diagnostic laparoscopy, cecopexy with appendectomy 10/2018. She has chronic nausea, slow gastric motility and reoccurring small bowel obstructions. She presented to the emergency department with increase in abdominal pain, nausea and vomiting. Onset of symptoms: Sunday. Intermittent abd pain until yesterday when it became more constant. Passed small loose BM yesterday, was passing gas, and heard bowel sounds so patient did not get concerned until symptoms progressively worsened despite home remedies including Gas X, magnesium, a probiotic, peppermint tea, positioning, and clear liquid diet. Emesis X 2. Pain described as cramping/twisting in lower abdomen similar to prior obstructions. Reports 7 prior bowel obstructions since 2018. Pain radiates throughout abdomen. Pain is aggrevated by eating and alleviated with pain medications. She follows a low fiber/low residue diet. She underwent a full examination including a CT scan of her abd/pelvis which is concerning for a small bowel obstruction.  She denies recent illness and has received COVID-19 vaccine.  1/6/22: Patient presented to the ED on January 3, 2022 with complaints of severe nausea, abdominal pain, and vomiting x 1 day.  Imaging showed partial small bowel obstruction.  NG tube was placed.  Patient was admitted for observation. Oral triple therapy was started.  Her COVID-19 test result was positive.  The hospitalist service was consulted. Patient began passing flatus and eventually passing stool. NG tube was removed and clear liquid diet was ordered and tolerated well.  The NG tube was removed and a low-fiber diet was ordered.  Patient was ambulating and voiding well. She was tolerating solid foods.  She voiced readiness for discharge.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Flatulence, Gastrointestinal tube insertion, Inappropriate schedule of product administration, Medical diet
Clinical narrative: Pfizer Dose 1 4/18/21 (lot NA) Pfizer Dose 2 5/13/21 (lot NA) COVID Positive 1/4/22  1/4/22: 50 year old female with PMHx of laparoscopic cholecystectomy 8/2018 followed by diagnostic laparoscopy, cecopexy with appendectomy 10/2018. She has chronic nausea, slow gastric motility and reoccurring small bowel obstructions. She presented to the emergency department with increase in abdominal pain, nausea and vomiting. Onset of symptoms: Sunday. Intermittent abd pain until yesterday when it became more constant. Passed small loose BM yesterday, was passing gas, and heard bowel sounds so patient did not get concerned until symptoms progressively worsened despite home remedies including Gas X, magnesium, a probiotic, peppermint tea, positioning, and clear liquid diet. Emesis X 2. Pain described as cramping/twisting in lower abdomen similar to prior obstructions. Reports 7 prior bowel obstructions since 2018. Pain radiates throughout abdomen. Pain is aggrevated by eating and alleviated with pain medications. She follows a low fiber/low residue diet. She underwent a full examination including a CT scan of her abd/pelvis which is concerning for a small bowel obstruction.  She denies recent illness and has received COVID-19 vaccine.  1/6/22: Patient presented to the ED on January 3, 2022 with complaints of severe nausea, abdominal pain, and vomiting x 1 day.  Imaging showed partial small bowel obstruction.  NG tube was placed.  Patient was admitted for observation. Oral triple therapy was started.  Her COVID-19 test result was positive.  The hospitalist service was consulted. Patient began passing flatus and eventually passing stool. NG tube was removed and clear liquid diet was ordered and tolerated well.  The NG tube was removed and a low-fiber diet was ordered.  Patient was ambulating and voiding well. She was tolerating solid foods.  She voiced readiness for discharge.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, SARS-CoV-2 test positive, Small intestinal obstruction, Vomiting
Clinical narrative: Pfizer Dose 1 4/18/21 (lot NA) Pfizer Dose 2 5/13/21 (lot NA) COVID Positive 1/4/22  1/4/22: 50 year old female with PMHx of laparoscopic cholecystectomy 8/2018 followed by diagnostic laparoscopy, cecopexy with appendectomy 10/2018. She has chronic nausea, slow gastric motility and reoccurring small bowel obstructions. She presented to the emergency department with increase in abdominal pain, nausea and vomiting. Onset of symptoms: Sunday. Intermittent abd pain until yesterday when it became more constant. Passed small loose BM yesterday, was passing gas, and heard bowel sounds so patient did not get concerned until symptoms progressively worsened despite home remedies including Gas X, magnesium, a probiotic, peppermint tea, positioning, and clear liquid diet. Emesis X 2. Pain described as cramping/twisting in lower abdomen similar to prior obstructions. Reports 7 prior bowel obstructions since 2018. Pain radiates throughout abdomen. Pain is aggrevated by eating and alleviated with pain medications. She follows a low fiber/low residue diet. She underwent a full examination including a CT scan of her abd/pelvis which is concerning for a small bowel obstruction.  She denies recent illness and has received COVID-19 vaccine.  1/6/22: Patient presented to the ED on January 3, 2022 with complaints of severe nausea, abdominal pain, and vomiting x 1 day.  Imaging showed partial small bowel obstruction.  NG tube was placed.  Patient was admitted for observation. Oral triple therapy was started.  Her COVID-19 test result was positive.  The hospitalist service was consulted. Patient began passing flatus and eventually passing stool. NG tube was removed and clear liquid diet was ordered and tolerated well.  The NG tube was removed and a low-fiber diet was ordered.  Patient was ambulating and voiding well. She was tolerating solid foods.  She voiced readiness for discharge.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Nasal congestion, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I tested positive on 06/08/2022 for COVID-19.  I had a scratchy throat, fever and nasal congestion.  I took Ibuprofen for the headache and a couple of throat lozenges for the scratchy throat.  I had a telehealth visit with a provider at an urgent care center because my primary care physician was not available. They prescribed Paxlovid.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation
Clinical narrative: I did not have an adverse reaction to the vaccine. I tested positive on 06/08/2022 for COVID-19.  I had a scratchy throat, fever and nasal congestion.  I took Ibuprofen for the headache and a couple of throat lozenges for the scratchy throat.  I had a telehealth visit with a provider at an urgent care center because my primary care physician was not available. They prescribed Paxlovid.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Asthenia
Clinical narrative: Discharge Provider:  MD Primary Care Provider:  MD Admission Date: 6/26/2022 Discharge Date: Jul 1, 2022  PRESENTING PROBLEM: Difficulty breathing [R06.89] Acute respiratory failure with hypoxia (HCC) [J96.01] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is a 95M  with Alzheimer's dementia, hearing loss, vertigo, previous stroke, sleep apnea, BPH, severe aortic stenosis status post TAVR, chronic systolic and diastolic heart failure and hypothyroidism who presented with a chief complaint of 1-2 days of fatigue/weakness and decreased appetite.   He was in his usual state of health until the day prior to presentation. He was out with family and when he returned, he had no appetite and did not eat dinner and this continued again in the morning. He also had an episode of diarrhea.   Upon arrival, he had a fever of 39° C and  mild leukocytosis of 11.19.  He had a mild nonproductive cough and his chest x-ray showed mild cardiomegaly and pulmonary vascular congestion, but no obvious infiltrate or pleural effusion.  Procalcitonin was negative (0.13). His SARS-CoV-2 PCR was negative. However, respiratory viral panel was sent and SARS-CoV-2 resulted positive there.   He was admitted for sepsis and acute respiratory failure due to COVID 19. He is fully vaccinated against COVID 19. CXR no infiltrate. CT angiogram thorax showing subsegmental right middle lobe pulmonary embolism no evidence of right heart strain. Echo with EF of 59% no WMA. He received remdesivir x5 days given acute hypoxemia. Levaquin started in ED but was not continued. He was weaned down to room air by discharge.   For his acute PE, he was transitioned from lovenox to eliquis with plan for 3 months of treatment. Home ASA 81 mg held while on eliquis to decrease bleeding risk.   He appeared to have a mild acute kidney injury compared to his previous baseline labs (0.89-- >1.06). UA negative for UTI. Renal function improved to baseline by discharge.   He did develop mild delirium/acute encephalopathy in the setting of known dementia. He has hearing loss which makes it harder to communicate. He is known to lip read which makes it harder for him to understand his care team with mask on. No treatment needed for his acute confusion. Frequent redirection, avoiding sedative/narcotics and encourage proper sleep wake cycle was re inforced.   PT/OT recommend SAR and he was discharged to facility in stable condition on 7/1/22